Can Felodipine Cause GORD?
Felodipine does not appear to cause or worsen gastro-oesophageal reflux disease (GORD) based on the available evidence, making it a safer calcium channel blocker choice compared to other agents in this class.
Evidence from FDA Drug Labeling
The official FDA prescribing information for felodipine 1 does not list GORD, reflux, or any gastrointestinal symptoms related to esophageal dysfunction as recognized adverse effects. The most common adverse event reported is peripheral edema (10-30% depending on age and dose), along with hypotension, reflex tachycardia, and gingival hyperplasia. The absence of GORD-related warnings in the drug label is notable.
Direct Research Evidence on Felodipine
A specific study examining felodipine's effect on GORD patients 2 provides reassuring data. Nine patients with established GORD underwent 47-hour ambulatory pH monitoring before and after receiving 5 mg felodipine. No significant differences were found in any reflux parameter, including:
- Number of reflux episodes (P = 0.552)
- Reflux episodes lasting >5 minutes (P = 0.683)
- Esophageal acid clearance (P = 0.663)
- Fraction of time with pH <4 (P = 0.752)
This demonstrates that felodipine neither increases reflux episodes nor impairs the esophagus's ability to clear acid.
Context: Calcium Channel Blockers as a Class
While calcium channel blockers as a class have been implicated in GORD, not all agents carry equal risk. A retrospective observational study of 371 patients 3 found significant differences among calcium channel blockers:
- Amlodipine: Highest rate of worsening reflux symptoms (61.3%, P ≤0.0001)
- Verapamil: Highest rate of new-onset symptoms (39.1%, P = 0.001)
- Diltiazem: Lowest rates overall (12.5% worsening, 30.7% new-onset)
- Felodipine: Not specifically highlighted as problematic
The mechanism by which some calcium channel blockers worsen GORD involves reducing lower esophageal sphincter pressure 4, 5, but this effect varies considerably among individual agents.
Clinical Implications
If you have a patient requiring calcium channel blocker therapy who also has GORD:
- Felodipine appears to be a safe choice based on direct evidence
- Diltiazem is another reasonable alternative with lower GORD risk
- Avoid nifedipine, amlodipine, and verapamil if GORD is a concern
- No dose adjustment or additional GORD prophylaxis is needed specifically for felodipine
Common pitfall to avoid: Do not assume all calcium channel blockers have equivalent effects on GORD. The class effect is not uniform, and felodipine specifically has been studied and found not to worsen reflux parameters.
Interestingly, recent genetic evidence 6 even suggests that some calcium channel blockers (specifically amlodipine) may have protective effects against GERD through calcium signaling pathways, though this requires further validation and appears contradictory to observational data showing amlodipine worsens symptoms.